Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Biomarker”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT00324714
What this trial is testing

Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS

Who this might be right for
Breast CancerOsteoporosis
ETOP IBCSG Partners Foundation
Not applicableStudy completedNCT01834014
What this trial is testing

Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases

Who this might be right for
Liver MetastasisColorectal Cancer
EPS Corporation 110
Very early researchStudy completedNCT06378398
What this trial is testing

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

Who this might be right for
Colorectal Neoplasia
University of Michigan Rogel Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT04025593
What this trial is testing

Biomarker Guided Treatment in DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 128
Not applicableStudy completedNCT03401034
What this trial is testing

Influence of Lifestyle, Inflammatory Biomarkers, and Genetic Factors on Long-term Breast Cancer Prognosis

Who this might be right for
Breast CancerBreast Cancer MortalityBreast Cancer Survival+7 more
German Cancer Research Center 3,813
Not applicableEnded earlyNCT03727009
What this trial is testing

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies

Who this might be right for
Hematologic Malignancy
Exact Sciences Corporation 409
Not applicableWithdrawnNCT02778295
What this trial is testing

Biomarker for Patients With Fabry Disease (BioFabry)

Who this might be right for
AngiokeratomasChronic Kidney DiseaseOcular Abnormalities+1 more
CENTOGENE GmbH Rostock
Not applicableLooking for participantsNCT05432739
What this trial is testing

Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study

Who this might be right for
Lung Cancer
Royal Marsden NHS Foundation Trust 500
Not applicableStudy completedNCT07744477
What this trial is testing

Validation of Serum Metabolite Differences in Patients With Gallstones and Gallbladder Cancer

Who this might be right for
Gallstone DiseaseGallbladder Malignant Neoplasm
Centre Paul Strauss 230
Early research (Phase 1)Ended earlyNCT02112162
What this trial is testing

Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery

Who this might be right for
Rectal Neoplasms
Washington University School of Medicine 2
Not applicableStudy completedNCT02272595
What this trial is testing

Rational Therapeutics Based on Matched Tumor and Normal Tissue

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 3
Not applicableUnknownNCT06309862
What this trial is testing

Immune Checkpoint Inhibitor Therapy for Cancer and Risk of Myocarditis or Cardiomyopathy

Who this might be right for
Cardio-OncologyCardiomyopathy Due to Drug
Sunnybrook Health Sciences Centre 15
Not applicableUnknownNCT01957241
What this trial is testing

PLA for HCC and Esophageal ca Serum

Who this might be right for
Hepatocellular CarcinomaEsophageal Cancer
National Taiwan University Hospital 164
Testing effectiveness (Phase 2)Looking for participantsNCT05950594
What this trial is testing

IVIM & OLINK in Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University Health Network, Toronto 145
Not applicableUnknownNCT02605941
What this trial is testing

DNA Methylation Biomarkers for Cervical Cancer Screening

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical Cancer
iStat Biomedical CO., Ltd. 5,000
Not applicableStudy completedNCT01858805
What this trial is testing

Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer

Who this might be right for
Resectable Esophageal Cancer
Universitätsklinikum Hamburg-Eppendorf 123
Not applicableLooking for participantsNCT03260842
What this trial is testing

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

Who this might be right for
Pancreatic CystPancreas Disease
Stanford University 500
Not applicableStudy completedNCT01361061
What this trial is testing

AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver

Who this might be right for
Liver Cirrhosis
University Hospital Freiburg 450
Early research (Phase 1)Ended earlyNCT00664586
What this trial is testing

Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors

Who this might be right for
Refractory Solid TumorsLymphoma
Erimos Pharmaceuticals 21
Not applicableStudy completedNCT04717427
What this trial is testing

Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome

Who this might be right for
Sturge-Weber Syndrome
University of Illinois at Chicago 161
Next Page